Manufacturing breakthroughs are set to transform cell therapy production, paving the way for faster trials and wider patient …
Manufacturing breakthroughs are set to transform cell therapy production, paving the way for faster trials and wider patient …
AI-driven drug discovery is accelerating innovation and transforming biopharma R&D.
Australia’s National Genomic Registry is connecting patients, clinicians, and researchers to transform rare disease care in real time.
Australian-led clinical trials are advancing the future of diabetes care with oral insulin innovations.
New partnerships in real-time genomics promise faster, more accurate diagnoses for pediatric rare diseases.
A promising vaccine candidate advances efforts to combat neglected tropical diseases with mRNA innovation.
Partnership targets Alzheimer’s and Parkinson’s with novel delivery platforms and precision medicine approaches.
A pivotal step forward for Duchenne families as gene therapy shows promise to transform neuromuscular care.
A historic breakthrough as the first CRISPR-based gene-editing therapy gains FDA approval, offering new hope for sickle cell …
Already a subscriber? Log in